Pharmaceutical Composition With Synergistic Anticonvulsant Effect

Patent No. EP2695618 (titled "Pharmaceutical Composition With Synergistic Anticonvulsant Effect") was filed by UCB Pharma on Jun 15, 2007. The application was issued on May 11, 2022.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HELM AGJun 24, 2015UEXKULL & STOLBERG
POLPHARMAJun 24, 2015CHMURZYNSKI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2695618

UCB PHARMA
Application Number
EP13004798A
Filing Date
Jun 15, 2007
Status
Patent Maintained As Amended
Apr 8, 2022
Publication Date
May 11, 2022